Selenomethionine inhibits IL-1beta inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes
Book an appointment at DripGym today and experience clinical-grade hangover recovery
Most Common Adverse Events Key Observations: Gastrointestinal adverse events are dose-dependent and most pronounced during dose escalation Symptoms typically peak within the first 4-8 weeks and diminish with continued treatment as tolerance develops Slow titration (4-week intervals) significantly reduces the incidence and severity of GI events Most adverse events classified as mild to moderate in severity [9] Discontinuation Rates 7.3% Placebo discontinuation rate [9] 15.8% Cagrilintide 2.4 mg (optimal dose) [9] 24.5% Cagrilintide 4.5 mg (high dose) [9] The majority of discontinuations due to adverse events occurred during the titration phase, with GI symptoms (nausea, vomiting) being the primary reasons
The Future of GLP-1 Therapy: Why Were Only at the Beginning December 22, 2025 This one is about where this field is heading
It has the potential to offer numerous insights, including improved understanding of disease pathophysiology, delineation of mechanisms of action for current treatment strategies, development of biomarkers to predict treatment response and disease progression, and identification of novel therapeutic targets 7
